Thermo Fisher microbiology business Acquired by Astorg | Healthcare M&A Deal

Astorg has acquired Thermo Fisher microbiology business, a diagnostics imaging business in the healthcare sector, for $1bn. The Thermo Fisher microbiology business provides microbiology testing and related diagnostic services that support clinical laboratories and healthcare providers. Astorg acquisitions in diagnostics imaging acquisition aim to expand capabilities in microbiology workflows and strengthen its healthcare M&A footprint. The platform acquisition is structured as a private equity acquisition and is expected to close after regulatory review, with deal terms reported around $800m and additional valuation figures.